Speaker Details

David Miller, MD, PhD, FAAD

David Miller, MD, PhD, FAAD

SESSIONS

F032 What's New in the Management of Advanced Skin Cancer
Mar 20, 2027 • 1:00 PM - 3:00 PM
U047 Blood Testing for Skin Cancers: Updates on the Use of Liquid Biopsies in Cutaneous Oncology
Mar 21, 2027 • 8:00 AM - 9:00 AM
S058 Updates in Cutaneous Oncology
Mar 22, 2027 • 1:00 PM - 4:00 PM

DISCLOSURES

Almirall – Consultant (1099 relationship)(Fees); Avstera Therapeutics Corp – Advisory Board(Stock Options); Bristol Myers Squibb – Consultant (1099 relationship)(Fees); Castle Biosciences – Advisory Board(Fees); Checkpoint Therapeutics – Advisory Board(Honoraria), Advisory Board(Stock Options); Kartos Therapeutics – Investigator(Grants/Research Funding); Merck – Advisory Board(Honoraria); NeoImmuneTech – Investigator(Grants/Research Funding); Regeneron – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria); Xilio Therapeutics – Investigator(Grants/Research Funding);